We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
- Authors
Cairns, J A; Connolly, S J; Roberts, R; Gent, M
- Abstract
Survivors of acute myocardial infarction with frequent or repetitive ventricular premature depolarisations (VPDs) have higher mortality 1-2 years after the event than those without VPDs. Although there is no therapy of proven efficacy for such patients, previous studies of amiodarone have been encouraging. CAMIAT was a randomised double-blind placebo-controlled trial designed to assess the effect of amiodarone on the risk of resuscitated ventricular fibrillation or arrhythmic death among survivors of myocardial infarction with frequent or repetitive VPDs (> or = 10 VPDs per h or > or = 1 run of ventricular tachycardia).
- Publication
Lancet (London, England), 1997, Vol 349, Issue 9053, p675
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/s0140-6736(96)08171-8